Total Payments
$8,436
2024 Payments
$971.33
Companies
37
Transactions
509
Medicare Patients
3,244
Medicare Billing
$406,702
Payment Breakdown by Category
Food & Beverage$8,422 (99.8%)
Education$12.32 (0.1%)
Other$1.87 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $8,422 | 503 | 99.8% |
| Education | $12.32 | 2 | 0.1% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $1.87 | 4 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $1,570 | 135 | $0 (2024) |
| United Therapeutics Corporation | $937.14 | 33 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $785.62 | 50 | $0 (2024) |
| Grifols USA, LLC | $701.01 | 62 | $0 (2024) |
| Actelion Pharmaceuticals US, Inc. | $537.30 | 27 | $0 (2024) |
| Genentech USA, Inc. | $328.80 | 18 | $0 (2024) |
| Merck Sharp & Dohme LLC | $278.65 | 14 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $270.76 | 15 | $0 (2023) |
| GENZYME CORPORATION | $263.79 | 15 | $0 (2023) |
| Sunovion Pharmaceuticals Inc. | $218.71 | 13 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $971.33 | 43 | AstraZeneca Pharmaceuticals LP ($135.42) |
| 2023 | $1,217 | 65 | GlaxoSmithKline, LLC. ($178.36) |
| 2022 | $1,006 | 64 | Grifols USA, LLC ($175.91) |
| 2021 | $850.91 | 55 | United Therapeutics Corporation ($208.82) |
| 2020 | $483.67 | 33 | GlaxoSmithKline, LLC. ($166.80) |
| 2019 | $1,316 | 93 | GlaxoSmithKline, LLC. ($295.08) |
| 2018 | $1,077 | 73 | GlaxoSmithKline, LLC. ($303.61) |
| 2017 | $1,514 | 83 | United Therapeutics Corporation ($360.74) |
All Payment Transactions
509 individual payment records from CMS Open Payments — Page 2 of 21
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/08/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $18.85 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 05/07/2024 | Novartis Pharmaceuticals Corporation | XOLAIR (Drug) | Food and Beverage | In-kind items and services | $19.55 | General |
| Category: Pulmonary/Respiratory Diseases | ||||||
| 05/01/2024 | United Therapeutics Corporation | TYVASO (Drug) | Food and Beverage | In-kind items and services | $23.95 | General |
| Category: Pulmonary Arterial Hypertension and Pulmonary Hypertension with Interstitial Lung Disease | ||||||
| 04/30/2024 | JAZZ PHARMACEUTICALS INC. | XYWAV (Drug) | Food and Beverage | In-kind items and services | $36.23 | General |
| Category: NEUROLOGY | ||||||
| 04/19/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $17.04 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 04/15/2024 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug), OPSUMIT | Food and Beverage | In-kind items and services | $29.93 | General |
| Category: Cardiology | ||||||
| 04/10/2024 | Merck Sharp & Dohme LLC | DIFICID (Drug), RECARBRIO, ZERBAXA | Food and Beverage | In-kind items and services | $19.89 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 04/10/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $18.11 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 03/28/2024 | Novartis Pharmaceuticals Corporation | XOLAIR (Drug) | Food and Beverage | In-kind items and services | $21.90 | General |
| Category: Pulmonary/Respiratory Diseases | ||||||
| 03/21/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $17.47 | General |
| Category: RESPIRATORY | ||||||
| 03/13/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $22.10 | General |
| Category: RESPIRATORY | ||||||
| 02/27/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $18.95 | General |
| Category: Respiratory | ||||||
| 02/27/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $15.04 | General |
| Category: Respiratory | ||||||
| 02/26/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $9.77 | General |
| Category: Respiratory | ||||||
| 02/22/2024 | Bayer Healthcare Pharmaceuticals Inc. | Adempas (Drug) | Food and Beverage | In-kind items and services | $17.13 | General |
| Category: Cardio-pulmonary | ||||||
| 02/21/2024 | Genentech USA, Inc. | Xolair (Biological) | Food and Beverage | In-kind items and services | $24.17 | General |
| Category: Immunology | ||||||
| 02/21/2024 | Azurity Pharmaceuticals, Inc. | HORIZANT (Drug) | Food and Beverage | In-kind items and services | $22.38 | General |
| Category: CEREBROVASCULARCNS | ||||||
| 02/14/2024 | Grifols USA, LLC | Prolastin-C Liquid (Biological) | Food and Beverage | In-kind items and services | $13.28 | General |
| Category: Pulmonology | ||||||
| 12/01/2023 | Grifols USA, LLC | Prolastin-C Liquid (Biological) | Food and Beverage | In-kind items and services | $4.73 | General |
| Category: Pulmonology | ||||||
| 11/16/2023 | Grifols USA, LLC | Prolastin-C Liquid (Biological) | Food and Beverage | In-kind items and services | $14.50 | General |
| Category: Pulmonology | ||||||
| 11/16/2023 | Grifols USA, LLC | Prolastin-C Liquid (Biological) | Food and Beverage | In-kind items and services | $1.09 | General |
| Category: Pulmonology | ||||||
| 11/14/2023 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $20.29 | General |
| Category: Immunology | ||||||
| 11/13/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $24.58 | General |
| 11/10/2023 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug), OPSUMIT | Food and Beverage | In-kind items and services | $25.58 | General |
| Category: Cardiology | ||||||
| 11/02/2023 | JAZZ PHARMACEUTICALS INC. | XYWAV (Drug) | Food and Beverage | In-kind items and services | $33.03 | General |
| Category: NEUROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 17 | 934 | 1,303 | $350,911 | $114,522 |
| 2022 | 15 | 722 | 1,039 | $268,584 | $87,620 |
| 2021 | 16 | 809 | 1,138 | $309,271 | $104,670 |
| 2020 | 19 | 779 | 1,101 | $303,464 | $99,891 |
Total Patients
3,244
Total Services
4,581
Medicare Billing
$406,702
Procedure Codes
79
All Medicare Procedures & Services
79 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 130 | 270 | $139,050 | $43,266 | 31.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 131 | 216 | $55,728 | $19,564 | 35.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 65 | 99 | $28,116 | $12,232 | 43.5% |
| 99292 | Critical care, each additional 30 minutes | Facility | 2023 | 66 | 142 | $36,636 | $11,398 | 31.1% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 35 | 35 | $14,210 | $5,464 | 38.5% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 27 | 45 | $9,585 | $4,026 | 42.0% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2023 | 71 | 72 | $10,512 | $3,121 | 29.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 44 | 48 | $7,344 | $2,934 | 40.0% |
| 94727 | Test to determine lung volumes using gas dilution or washout | Office | 2023 | 69 | 70 | $6,720 | $2,338 | 34.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 19 | 19 | $6,992 | $2,259 | 32.3% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 15 | 16 | $6,928 | $2,115 | 30.5% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2023 | 69 | 70 | $10,710 | $2,066 | 19.3% |
| 36556 | Insertion of non-tunneled central venous tube for infusion (5 years or older) | Facility | 2023 | 17 | 18 | $7,128 | $1,130 | 15.9% |
| 94618 | Test for exercise-induced lung stress | Office | 2023 | 42 | 42 | $2,730 | $1,057 | 38.7% |
| 94375 | Test to measure rate of airflow | Office | 2023 | 15 | 16 | $1,696 | $469.44 | 27.7% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Facility | 2023 | 44 | 44 | $1,936 | $279.49 | 14.4% |
| 94762 | Test to measure oxygen level in blood using ear or finger device continuously overnight | Office | 2023 | 13 | 14 | $1,162 | $271.60 | 23.4% |
| 76937 | Ultrasonic guidance for blood vessel access | Facility | 2023 | 18 | 22 | $1,298 | $223.44 | 17.2% |
| 94727 | Test to determine lung volumes using gas dilution or washout | Facility | 2023 | 21 | 21 | $1,134 | $163.98 | 14.5% |
| 94729 | Test to examine how well the lungs exchange gases | Facility | 2023 | 23 | 24 | $1,296 | $141.54 | 10.9% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 105 | 178 | $91,670 | $29,424 | 32.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 103 | 185 | $47,730 | $16,985 | 35.6% |
| 99292 | Critical care, each additional 30 minutes | Facility | 2022 | 71 | 171 | $44,118 | $14,150 | 32.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 74 | 92 | $14,076 | $5,616 | 39.9% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 25 | 49 | $10,437 | $3,811 | 36.5% |
About Dr. Nimeshkumar Mehta, M.D
Dr. Nimeshkumar Mehta, M.D is a Internal Medicine healthcare provider based in Salem, Oregon. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/19/2011. The National Provider Identifier (NPI) number assigned to this provider is 1184923930.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Nimeshkumar Mehta, M.D has received a total of $8,436 in payments from pharmaceutical and medical device companies, with $971.33 received in 2024. These payments were reported across 509 transactions from 37 companies. The most common payment nature is "Food and Beverage" ($8,422).
As a Medicare-enrolled provider, Mehta has provided services to 3,244 Medicare beneficiaries, totaling 4,581 services with total Medicare billing of $406,702. Data is available for 4 years (2020–2023), covering 79 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Critical Care Medicine, Pulmonary Disease
- Location Salem, OR
- Active Since 03/19/2011
- Last Updated 02/15/2013
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1184923930
Products in Payments
- NUCALA (Biological) $727.24
- Prolastin-C Liquid (Biological) $662.59
- ORENITRAM (Drug) $504.64
- TRELEGY ELLIPTA (Drug) $480.43
- DUPIXENT (Biological) $391.87
- TYVASO (Drug) $374.50
- UPTRAVI (Drug) $307.77
- SYMBICORT (Drug) $296.65
- Xolair (Biological) $249.72
- Arikayce (Drug) $216.64
- Adempas (Drug) $176.30
- XYWAV (Drug) $166.60
- GLASSIA (Biological) $158.26
- BREZTRI (Drug) $156.04
- TUDORZA PRESSAIR (Drug) $153.88
- ANORO (Drug) $149.98
- BREO (Drug) $144.11
- OFEV (Drug) $141.49
- TEZSPIRE (Biological) $134.68
- OPSUMIT (Drug) $131.27
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Salem
Dr. Michael Katcher, Md, MD
Internal Medicine — Payments: $124,347
Internal Medicine $124,347
Jonh Pineda-Bonilla, Md, MD
Internal Medicine — Payments: $51,042
Internal Medicine $51,042
Dr. Garry Miller, D.o, D.O
Internal Medicine — Payments: $17,070
Internal Medicine $17,070
David Bennion, Md, MD
Internal Medicine — Payments: $13,939
Internal Medicine $13,939
Mr. Gautam Jha, Md, MD
Internal Medicine — Payments: $11,191
Internal Medicine $11,191
Dr. Troy Lunceford, Md, MD
Internal Medicine — Payments: $10,868
Internal Medicine $10,868